VETERANS WHO HAVE A BRAIN DISORDER CAN GET IT FROM CHANGES IN THEIR BRAIN VECTOR, THE U.S. Department of Veterans Affairs says.
WASHINGTON (Reuters) – The Department of Veteran Affairs is testing new drugs that could help people who have a brain injury, a disorder that can cause epilepsy.
VA said on Thursday that it had approved two drug candidates that are part of a clinical trial for treating the condition.
It said it expects to make a decision on the other by the end of the year.
The drugs, called fenfluramine and viread, are part to the brain-injury drug regimen of the VA, which is trying to make sure it is able to treat the disorder.
The drugs were developed by Sanofi Pasteur Corp and the University of Illinois at Chicago.
Fenfloramine and Viread were approved for use in the U.K. and the U-Maine Veterans Affairs system, which has about 4,000 members.
“The goal is to reduce the number of people in this country who are in serious, potentially life-threatening situations because they have epilepsy,” said Dr. Matthew Henningsen, VA’s chief medical officer.
More: Vaccines that protect against autism, Alzheimer’s and other brain diseases are a major priority for the VA.
Veterans and their families need to understand that the diagnosis and treatment of epilepsy is complex and the likelihood of being successful in treating the disorder is high,” Henniesen said.
They also need to know how they can help others and avoid having epilepsy that can impact their ability to function.
Virtually every VA patient with epilepsy will have some symptoms, including sleep disturbances and difficulty concentrating.